ST
EPRS

Spot Trading’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Spot Trading’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-60,519
Closed -$187K – 4557
2015
Q4 		$187K Buy
60,519
+36,038
+147% +$162K ﹤0.01% 2516
2015
Q3 		$108K Buy
+24,481
New +$144K ﹤0.01% 3014

Other funds holding EPRS

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Spot Trading's EPRS Position: Q1 2016 in Review

Spot Trading sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q1 2016, closing a stake of 60,519 shares — an estimated $187K sold.

Spot Trading first reported a position in EPRS in Q3 2015 and held it in 2 quarters. The position peaked at $187K in Q4 2015. 37 funds tracked by Wall St. Rank hold EPRS as of Q1 2016.

  • Spot Trading reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 60,519 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q1 2016, an estimated $187K.
  • Spot Trading first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2015 and held it in 2 quarters.
  • Spot Trading's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $187K in Q4 2015.
  • 37 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.